Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB

Objectives: We compared the pharmacokinetics of moxifloxacin during rifampicin co-treatment or when dosed alone in African patients with drug-susceptible recurrent TB. Methods: Patients in the intervention arm of the Improving Retreatment Success (IMPRESS) randomized controlled TB trial received 400...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Antimicrob Chemother
Egile Nagusiak: Naidoo, Anushka, Chirehwa, Maxwell, McIlleron, Helen, Naidoo, Kogieleum, Essack, Sabiha, Yende-Zuma, Nonhlanhla, Kimba-Phongi, Eddy, Adamson, John, Govender, Katya, Padayatchi, Nesri, Denti, Paolo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890691/
https://ncbi.nlm.nih.gov/pubmed/28175315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak